Viewing StudyNCT04802161



Ignite Creation Date: 2024-05-06 @ 3:55 PM
Last Modification Date: 2024-10-26 @ 1:59 PM
Study NCT ID: NCT04802161
Status: SUSPENDED
Last Update Posted: 2024-07-03
First Post: 2021-03-16

Brief Title: Comparing the Addition of an Anti-Cancer Drug Pomalidomide to the Usual Chemotherapy Treatment Daunorubicin and Cytarabine Liposome in Newly Diagnosed Acute Myeloid Leukemia With Myelodysplastic Syndrome-Related Changes
Sponsor: National Cancer Institute NCI
Organization: National Cancer Institute NCI

Conditions & Keywords Data

Conditions:
Name
Acute Myeloid Leukemia
Acute Myeloid Leukemia Post Cytotoxic Therapy
Acute Myeloid Leukemia With Multilineage Dysplasia
Chronic Myelomonocytic Leukemia
Myelodysplastic Syndrome
Myeloproliferative Neoplasm
Keywords: